| An mRNA vaccine against SARS-CoV-2—preliminary report LA Jackson, EJ Anderson, NG Rouphael, PC Roberts, M Makhene, ... New England journal of medicine 383 (20), 1920-1931, 2020 | 3467 | 2020 |
| Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ... New England Journal of Medicine 383 (25), 2427-2438, 2020 | 1600 | 2020 |
| Durability of responses after SARS-CoV-2 mRNA-1273 vaccination AT Widge, NG Rouphael, LA Jackson, EJ Anderson, PC Roberts, ... New England Journal of Medicine 384 (1), 80-82, 2021 | 814 | 2021 |
| Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19 N Doria-Rose, MS Suthar, M Makowski, S O’Connell, AB McDermott, ... New England Journal of Medicine 384 (23), 2259-2261, 2021 | 693 | 2021 |
| Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 520 | 2021 |
| Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase HM El Sahly, LR Baden, B Essink, S Doblecki-Lewis, JM Martin, ... New England Journal of Medicine 385 (19), 1774-1785, 2021 | 517 | 2021 |
| Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination E Pérez-Then, C Lucas, VS Monteiro, M Miric, V Brache, L Cochon, ... Nature medicine 28 (3), 481-485, 2022 | 341 | 2022 |
| Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants B Kampmann, SA Madhi, I Munjal, EAF Simões, BA Pahud, C Llapur, ... New England Journal of Medicine 388 (16), 1451-1464, 2023 | 281 | 2023 |
| Distinguishing features of Long COVID identified through immune profiling J Klein, J Wood, JR Jaycox, RM Dhodapkar, P Lu, JR Gehlhausen, ... Nature 623 (7985), 139-148, 2023 | 278 | 2023 |
| Herd immunity and implications for SARS-CoV-2 control SB Omer, I Yildirim, HP Forman Jama 324 (20), 2095-2096, 2020 | 259 | 2020 |
| A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine L Chu, R McPhee, W Huang, H Bennett, R Pajon, B Nestorova, B Leav, ... Vaccine 39 (20), 2791-2799, 2021 | 244 | 2021 |
| Delayed production of neutralizing antibodies correlates with fatal COVID-19 C Lucas, J Klein, ME Sundaram, F Liu, P Wong, J Silva, T Mao, JE Oh, ... Nature medicine 27 (7), 1178-1186, 2021 | 234 | 2021 |
| Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity C Lucas, CBF Vogels, I Yildirim, JE Rothman, P Lu, V Monteiro, ... Nature 600 (7889), 523-529, 2021 | 214 | 2021 |
| A prospective study of etiology of childhood acute bacterial meningitis, Turkey M Ceyhan, I Yildirim, P Balmer, R Borrow, B Dikici, M Turgut, N Kurt, ... Emerging infectious diseases 14 (7), 1089, 2008 | 168 | 2008 |
| The VACCINES Act: deciphering vaccine hesitancy in the time of COVID-19 J McAteer, I Yildirim, A Chahroudi Clinical Infectious Diseases 71 (15), 703-705, 2020 | 154 | 2020 |
| Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease I Yildirim, WP Hanage, M Lipsitch, KM Shea, A Stevenson, J Finkelstein, ... Vaccine 29 (2), 283-288, 2010 | 152 | 2010 |
| Inappropriate antimicrobial use in Turkish pediatric hospitals: a multicenter point prevalence survey M Ceyhan, I Yildirim, C Ecevit, A Aydogan, A Ornek, N Salman, A Somer, ... International Journal of Infectious Diseases 14 (1), e55-e61, 2010 | 141 | 2010 |
| Evaluation of mRNA-1273 Covid-19 vaccine in children 6 to 11 years of age CB Creech, E Anderson, V Berthaud, I Yildirim, AM Atz, I Melendez Baez, ... New England Journal of Medicine 386 (21), 2011-2023, 2022 | 134 | 2022 |
| Resistance to extended-spectrum cephalosporins, caused by PER-1 β-lactamase, in M Salmonella typhimurium from Istanbul, Turkey H Vahaboglu, LMC Hall, L Mulazimoglu, S Dodanli, I Yildirim, ... Journal of medical microbiology 43 (4), 294-299, 1995 | 129 | 1995 |
| The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: a systematic review and meta-analysis E Balsells, R Dagan, I Yildirim, PP Gounder, A Steens, C Muñoz-Almagro, ... Journal of Infection 77 (5), 368-378, 2018 | 118 | 2018 |
Saad B. OmerDirector, Yale Institute for Global HealthVerified email at yale.edu
